digipharm®
Home •  Site Map  •  Research  •  Reports  •  International Experts  •  Music Preparations  •  Fundamentals  •  News  •  Questions  •  Shop
digipharm®
peter huebner • micro music laboratories
M E D I C A L   R E S O N A N C E   T H E R A P Y   M U S I C®
R E D U C T I O N   O F   P S Y C H O – P H Y S I O L O G I C A L   M A N I F E S T A T I O N S   O F   S T R E S S

SCIENTIFIC RESEARCH

Research Fields Summary

Headaches

Migraine

Sleep Disorders

Pains

Neurodermatitis

Psoriasis

Medication Consumption

Dermatology

Dispersion of Stress

Faster Recovery

Mental Distress / Fear

Dizziness

Cardiovascular System

Hormone / Immune System

The Mental State

Operations

Radiation Sickness

ENT

Multiple Sclerosis

Gerontology

Diabetes

Cerebral & Nervous System

Mental & Sensory Abilities

Pediatrics

Pregnancy & Birth

Gynecology

Epilepsy

Concentration / Memory

Courage to Face Life

Creativity

Harmony

Mother & Child

Neurophysiological &
Sensory Disorders

Relaxation

Vital Energy

 

 






Scientific Studies and Clinical Observations
FASTER RECOVERY
  • Faster insulin process stabilization in children with diabetes: 64% of a group of diabetic children experienced a 2-3-day faster process stabilization than the children in the control group
  • Shorter stays in hospital for disfunctional juvenile uterine hemorrhage: the girls could be released from hospital an average of 2 days earlier than the girls in the control group; in 75% of the girls healing actually occurred twice as fast as in the control group, and they could already go home 3 days earlier
  • Healing-inducing effects in blood formation following gynecological surgery: at the end of the treatment only 26% of the results indicated anemia, compared to 39% in the control group
  • Faster normalization of the kidney function: breakdown of the protein content in the urine of pregnant women treated for OPH syndrome.
    The protein content of the urine was broken down within 4-5 days, significantly faster than in the control group
  • Faster normalization of high blood pressure in pregnant women than in a control group receiving hypotensive and sedative medicine
  • Dispersion of the clinical risk characteristics in pregnant women with health disorders which threatened to lead to miscarriage: already after a 2-3 days’ treatment there were no longer any clinical risk characteristics in 60% of the women patients.
    In the time from the fifth to the seventh day, these also disappeared in the remaining 40% of patients.
    In the control group the clinical risk characteristics in 70% of the women had disappeared after 7-10 days’ treatment. However, in 30% they remained
  • Shorter stays in hospital: a 35% faster recovery in pregnant women with health disorders which threatened to lead to miscarriage than those in the control group
  • Faster recovery in high-risk pregnancies with an OPH syndrome: in this group treatment could be completed 14% faster than in the control group
 


  For this indication please use the program:

VITAL ENERGY
 
 
 

   If you want to look at the studies in detail, please visit:

With kind permission of AAR EDITION INTERNATIONAL
© 1998-  DIGIPHARM >